BIOA

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total common shares outstanding 35.85 M35.85 M35.85 M35.85 M35.86 M — Enterprise value 411.15 M-146.73 M-122.69 M-72.27 M-4.75 M -346.43 M Price to earnings ratio —-0.87—0.510.41 — Price to sales ratio —203.63—38.3335.63 — Price to cash flow ratio —1.21—0.712.99 — Price to book ratio —0.19—0.030.11 — Enterprise value to EBITDA ratio ————— — Return on assets % 0.070.060.040.070.07 0.23 Return on equity % 0.070.070.040.070.07 0.25 Return on invested capital % —329.13——— — Gross margin % ——100100100 — Operating margin % ——1 133.431 026.991 126.58 — EBITDA margin % ————— — Net margin % ——890.97893.99982.04 — Quick ratio ————— — Current ratio 17.6312.8613.6813.2111.87 51.63 Inventory turnover ————— — Asset turnover 0000.010.01 0.02 Debt to assets ratio ————— — Debt to equity ratio ————— — Long term debt to total assets ratio 0.010.01000 0.01 Long term debt to total equity ratio 0.010.01000 0.01 Operating cash flow per share 4.270.480.480.560.45 1.97 EBIT per share ————— — EBITDA per share ————— — Total debt per share ————— — Cash per share 95.7233.038.948.297.97 58.24 Net current asset value per share 96.2833.299.068.428.11 58.88 Tangible book value per share 89.7830.128.748.227.74 54.82 Working capital per share 90.8230.78.47.787.43 54.31 Book value per share 89.7830.128.748.227.74 54.82